Sinonasal adenocarcinoma: Immunohistochemical marking and expression of oncoproteins

Head and Neck

Volumn 25, Issue 9, 2003, Pages 763-771

  Bashir, Amani A ^a   Robinson, Robert A ^a   Benda, Jo A ^a   Smith, Russell B ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Adenocarcinoma; Cytokeratin; Metastasis; Oncoproteins; Sinonasal

Indexed keywords

ACTIN; AE 1 PROTEIN; AE 3 PROTEIN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; DESMIN; KERATIN; MUSCLE SPECIFIC ACTIN; ONCOPROTEIN; PROTEIN; PROTEIN P53; PROTEIN S 100; SMOOTH MUSCLE SPECIFIC ACTIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; NOSE CARCINOMA; ONCOGENE; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINONASAL ADENOCARCINOMA; STAINING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PARANASAL SINUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0042888964     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10285     Document Type: Article

References (26)

1. Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986;10:192-202.
2. Alessi DM, Trapp TK, Fu YS, Calcaterra TC. Nonsalivary sinonasal adenocarcinoma. Arch Otolaryngol Head Neck Surg 1988;114:996-999.
3. Moran CA, Wenig BM, Mullick FG. Primary adenocarcinoma of the nasal cavity and paranasal sinuses. Ear Nose Throat J 1991;70:821-828.
4. Cawte T, Taskin M, Kacker A, Wahl S. Low-grade adenocarcinoma of nasal passages. Otolaryngol Head Neck Surg 1997;117:116-119.
5. Franquemont DW, Fechner RE, Mills SE. Histologic classification of sinonasal intestinal-type adenocarcinoma. Am J Surg Pathol 1991;15:368-375.
6. Franchi A, Gallo O, Santucci M. Clinical relevance of the histological classification of sinonasal intestinal-type adenocarcinomas. Hum Pathol 1999;30:1140-1145.
7. Lessard J, Robinson RA, Hoffman HT. Differential expression of ras signal transduction mediators in verrucous and squamous cell carcinomas of the upper aerodigestive tract. Arch Path Lab Med 2001;125:1200-1203.
8. Batsakis JG, Rice DH, Solomon AR. The pathology of head and neck tumors: Squamous and mucous-gland carcinomas of the nasal cavity, paranasal sinuses, and larynx, part 6. Head Neck Surgery 1980;2:497-508.
9. Gnepp DR, Heffner DK. Mucosal origin of sinonasal tract adenomatous neoplasms. Mod Pathol 1989;2:365-371.
10. Goepfert H, Luna MA, Lindberg RD, White AK. Malignant salivary gland tumors of the paranasal sinuses and nasal cavity. Arch Otolaryngol 1983;109:662-668.
11. Salassa JR, McDonald TJ, Weiland LH. 'Colonic type' adenocarcinoma of the nasal cavity and paranasal sinuses. Otolaryngol Head Neck Surg 1980;88:133-135.
12. Sanz JJ, Martinez P, Aguilar F, Bernal Sprekelsen M, Nadal A. Adenocarcinoma de tipo intestinal nasosinusal: a proposito de siete casos. Acta Otorrinolaring Esp 2000;51:599-602.
13. Klintenberg C, Olofsson J, Hellquist H, Sökjer H. Adenocarcinoma of the ethmoid sinuses. A review of 28 cases with special reference to wood dust exposure. Cancer 1984;54:482-488.
14. Bernstein JM, Montgomery WW, Balogh K Jr. Metastatic tumors to the maxilla, nose and paranasal sinuses. Laryngoscope 1966;76:621-650.
15. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-972.
16. Tot T. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer 1999;85:171-177.
17. Loy TS, Calaluce RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 1994;102:764-767.
18. McKinney CD, Mills SE, Franquemont DW. Sinonasal intestinal-type adenocarcinoma: Immunohistochemical profile and comparison with colonic adenocarcinoma. Mod Pathol 1995;8:421-426.
19. Krane J, O'Connell J, Pilch B, Faquin W. Cytokeratin and mucin expression in intestinal-type sinonasal adenocarcinomas. Mod Path 2000;13:814.
20. Ritter J, Boucher L, Wick M. Peripheral pulmonary adenocarcinomas with bronchioloalveolar features: immunophenotypes correlate with histologic patterns. Mod Pathol 1998;11:566-572.
21. Wang N, Zee S, Zarbo R, Bacchi C, Gown A. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995;3:99-101.
22. Baisse B, Bouzourene H, Saraga EP, Bosman FT, Benhattar J. Intratumor genetic heterogeneity in advanced colorectal adenocarcinoma. International J Cancer 2001;93:346-352.
23. Bosari S, Viale G, Roncalli M, et al. p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol 1995;147:790-798.
24. Berney CR, Fisher RJ, Yang JL, Russel PJ, Crowe PJ. Protein markers in colorectal cancer. Ann Surg 1999;230:179-184.
25. Diez M, Pollan M, Mjuguerza JM, et al. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma. Cancer 2000;88:35-41.
26. Gallo O, Franchi A, Fini-storchi I, et al. Prognostic significance of c-erbB-2 oncoprotein expression in intestinal-type adenocarcinoma of the sinonasal tract. Head Neck 1998;224-231.